Abstract
A 56-year-old man with a history of asthma and anxiety presented for further evaluation of his ongoing neurological decline. He reported being in good neurological health until a few years ago, when he developed left hand clumsiness followed by some difficulty ambulating due to fatigable weakness in his left leg. He noticed that his left leg would become weak while walking long distances but then would improve after resting. These symptoms prompted neurophysiological studies that demonstrated mild bilateral median neuropathies at the wrist, which was thought to be contributing to his hand symptoms. Lower extremity neurophysiological testing did not reveal a polyneuropathy, myopathy, or radiculopathy. He subsequently underwent a lumbar spine MRI for his ambulation difficulties that demonstrated some degenerative disk disease, but no spinal stenosis or nerve root compression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lublin F, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology 2014;83;278-286.
Koch M, Kingwell E, Rieckmann P, Tremlett H. The natural history of primary progressive multiple sclerosis. Neurology 2009;73:1996-2002.
Naismith RT, Trinkaus K, Cross AH. Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Mult Scler. 2006;12:775-781.
Koch MW, Greenfield J, Javizian O, Deighton S, Wall W, Metz LM. The natural history of early versus late disability accumulation in primary progressive MS. J Neurol Neurosurg Psychiatry. 2015;86:615-621.
Bernitsas E, Bao F, Seraji-Bozorgzad N, et al. Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes. Mult Scler Relat Disord. 2015;4:47-51.
Tur C, Penny S, Khaleeli Z, et al. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis. Mult Scler. 2011 17:1324-1332.
Lucchinetti CF, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47:707-717.
Iwanowski P, Losy J. Immunological differences between classical phenotypes of multiple sclerosis. J Neurol Sci. 2015;349:10-14.
Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292-302.
Hawker K, O’Connor P, Freedman MS, et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol. 2009;66:460-471.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Newsome, S.D. (2017). Diagnosing primary progressive multiple sclerosis. In: Giacomini, P. (eds) Case Studies in Multiple Sclerosis. Adis, Cham. https://doi.org/10.1007/978-3-319-31190-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-31190-6_8
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-31188-3
Online ISBN: 978-3-319-31190-6
eBook Packages: MedicineMedicine (R0)